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Abstract: One-hundred and sixty-four migrants from Sub-Saharan Africa to Italy were screened with
the Taenia solium specific enzyme-linked immunosorbent assay coproantigen (ELISA CoAg) and four
(2.4%) were recorded as positive, but with optical density values near to the cut-off. No ELISA CoAg
positive samples were confirmed by parasitological methods. Low positivity could be attributed to
false positive result or cross-reaction with other Taenia species. Further studies are needed to assess
the role of migration on sporadic autochthonous transmission of T. solium taeniasis/cysticercosis
in Europe.
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1. Introduction
Taenia solium taeniasis/cysticercosis is a public health concern in several middle- and low-income
countries, including countries in the region of Sub-Saharan Africa (SSA), where the prevalence of
tapeworm carriers ranges from 1.5% to 5% [1], and neurocysticercosis is responsible of 30% of cases of
epilepsy [2]. Traditional parasitological examination of stool has a low sensitivity, ranging from 0% to
63% [3], and is not usually able to differentiate human tapeworm species, since the eggs of T. solium, T.
saginata and T. asiatica are morphologically indistinguishable and the differentiation based on scolices,
which are rarely recovered intact, and mature proglottids is not always feasible [4]. The species-specific
enzyme-linked immunosorbent assay (ELISA) coproantigen (CoAg) for the diagnosis of T. solium
taeniasis has shown a higher sensitivity (81–100%) and specificity (99%) [3].
The complete life cycle of T. solium taeniasis/cysticercosis probably no longer occurs in Italy, since
the last autochthonous T. solium taeniasis case diagnosed in Italy was recorded in Sicily in 1985, and
cases of porcine cysticercosis were not detected in a survey carried out in 2007 in Italy [5–7].
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However, migration from endemic countries may theoretically ignite reintroduction of the parasite
and sporadic autochthonous transmission in receiving countries. T. solium tapeworm carriers can cause
foci of neurocysticercosis, even among contacts who do not eat pork and have not traveled to a country
where the parasite is endemic [8]. A recent review has identified 78 cases of United States (US)-acquired
cysticercosis, in both foreign and US-born populations [9]. Migration flows from SSA to Europe were
particularly intense in recent years. In the period of 2014–2019, 650,000 migrants disembarked in
Italy, the majority from SSA [10]. In 2014, 274 asylum seekers hosted in a large reception center in
Sicily were tested with the parasitological examination of stool and six (2.16%), all from the Horn of
Africa (five from Eritrea and one from Ethiopia, respectively), were found positive for Taenia spp. eggs.
Data on Taenia species were not available in this study [11]. We report the results of a study aimed at
investigating the prevalence of T. solium taeniasis in a population of SSA migrants recently arrived in
Italy using the species-specific ELISA coproantigen (CoAg).
2. Results
Six-hundred and thirty-nine people participated in health information meetings, 40% (254/639)
agreed to participate in the study, and 64% (164/254) provided a stool sample. All the participants to
this study were males. The median residency time in Italy of subjects providing the stool sample was
28 months (range 7–36), and the median age was 24 years (range 18–49). The most frequent country
of origin was Nigeria (69/164, 42%), followed by Guinea (22/164, 13%) and Ivory Coast (16/164, 10%).
Twenty-seven (16%) reported consumption of pork, 42 (25%) denied it, and the remaining preferred
not to respond to this question.
The ELISA-CoAg was reactive on four (2.4%, 95% CI 0.1–4.7%) subjects. In three cases, the
ratio between Optical Density of the sample (ODs) and Optical Density of the positive pool (ODpp)
(ODs/ODpp) showed values near to the cut-off (borderline). No Taenia egg was detected in stool
samples by microscopy. Positivity was not associated with gastrointestinal or neurological symptoms.
The characteristics of subjects with a ELISA-CoAg reactive test are reported in Table 1. Interestingly,
of the five Somali men enrolled in the study, two (40%) had a positive ELISA CoAg [11]. Only one
patient was available for follow-up, while the remaining were lost to follow-up. The patient received
treatment with niclosamide (2 g orally repeated after one week) and was asked to bring stools obtained
over three days after the first niclosamide dose. The patient was instructed on the possible emission
of a tapeworm with his stool after the treatment. Iconographic material was used to show him
the macroscopic appearance of the worm, in a similar way to what was described by Flisser and
colleagues in their studies on self-diagnosis of taeniasis [12]. Only one stool sample was provided and
no proglottid or scolex were detected. The patient was contacted by telephone and denied having
eliminated any tapeworm. The enrollment was interrupted before the estimated sample size could be
reached, following a quick reduction in the number of migrants arriving in Italy in recent years due to
the changed geopolitical scenario.























37 Somalia 24 8.904 No Neg No Lost to follow-up
33 Somalia 22 7.949 No Neg No Lost to follow-up
27 Coted’Ivoire 20 9.332 No Neg No Lost to follow-up
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3. Discussion
Our findings do not confirm the presence of T. solium tapeworm carriers among recently arrived
migrants from SSA to Italy, since no reactive ELISA CoAg samples were confirmed by parasitological
methods and in three cases, ODs/ODpp showed values near to the cut-off. In this scenario, it is
impossible to determine if there was a T. solium infection. Usually, confirmed positive samples present
much higher values and weak positivity may be linked to false positive results or a cross-reaction with
other Taenia species. However, we cannot completely exclude the presence of T. solium infection based
on a negative microscopic examination of stool only, since this test has a low sensitivity. Furthermore,
since the treatment rate of niclosamide is not 100% [13], the absence of recovered scolex/proglottids
after treatment do not necessarily indicate that the treated patient was not infected. Moreover, only one
follow-up stool sample was tested. A low prevalence may be also explained by the fact that subjects
enrolled in this study were tested with a median time of 28 months from their arrival in Italy and T.
solium tapeworms are believed to live around three years [14], so it is possible that the parasite died
before our sampling. It must be noted that the majority of enrolled subjects come from countries where
the most common religion is Islam, which prohibits pork consumption. However, the same amount
of time between migration and testing, and almost the same origin/religion distribution, was also
present in the previous study on a similar population conducted by Patamia et al., which found a
higher prevalence of Taenia spp. at microscopy (2.16%) [11]. Further studies on migrant population,
based on a sensitive and specific diagnostic test for T. solium, such as the CoAg on a larger sample
with parasitological or molecular confirmation of positive samples, are needed to assess the possible
reemergence or sporadic autochthonous transmission of T. solium taeniasis/cysticercosis in nonendemic
European countries.
4. Materials and Methods
Between March 2018 and July 2019, a prevalence study on T. solium taeniasis was carried out on
SSA migrants hosted in 12 reception centers for male subjects in five health districts of the province of
Florence and Prato, Tuscany Region, Italy.
The study was proposed on a voluntary basis to approximately 700 SSA adult migrants. Inclusion
criteria were being aged ≥ 18 years and arrived in Italy for less than three years before the enrollment
date. The exclusion criterion was a previous treatment for any parasitosis. A sample size of 640
subjects was required to allow an estimation of the prevalence of T. solium taeniasis with a confidence
interval of 90%, with a margin of error of 2.5% and an expected frequency of 1.5%. The study was
approved by the ethics committee of Area Vasta Centro on 16/01/2018 (code 12298_bio). Migrants were
invited to participate to the study during short information events on health topics (such as infectious
diseases prevention) delivered in English and French, with the help of cultural mediators when needed.
After having signed the informed consent, subjects willing to participate were asked to answer to a
short questionnaire to collect epidemiological and clinical information and to provide a stool sample
for direct parasitological examination and T. solium ELISA CoAg. Stool samples were collected and
preserved within four hours from the time of collection by homogenization in phosphate-buffered
saline and formaldehyde at 5% (10 g of stool with 40 ml, 1:4), and later sent to the Cysticercosis Unit,
Universidad Peruana Cayetano Heredia, Lima, Peru, for direct parasitological examination and T.
solium ELISA CoAg. The latter was performed according to Allan et al. [15] and considered reactive if
the ODs/ODpp was higher than 7.5.
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